Blog
Mesenchymal stem cells turn up in almost everything written about cell therapy: in clinical trials, in clinic advertising, and on the labels of supplements that contain none of them. This guide covers what they are, where they come from, what the evidence says they actually do, and what they are approved for today. It ends with the distinction that matters most before anyone spends money: why a capsule you swallow is not a cheaper version of a clinical procedure.
Mesenchymal stem cells, usually shortened to MSCs, are adult stromal cells that live in connective tissue and can turn into bone, cartilage and fat cells in the laboratory. They are not embryonic cells: they are collected from the tissue of adults or from donated birth tissue such as the umbilical cord and the placenta. The working definition used today was set by the International Society for Cell and Gene Therapy in 2006, and it has three parts: the cells must adhere to plastic in culture, they must carry the surface markers CD73, CD90 and CD105 while lacking CD45, CD34, CD14 and HLA-DR, and they must be able to form all three of those tissue types in a dish.
Even the name is debated among researchers. Arnold Caplan, who popularised the term in 1991, later argued that these cells behave less like spare parts and more like senders of chemical signals, and proposed calling them medicinal signaling cells instead. That shift in language tracks a real shift in what the research shows.
They are obtained from several different tissues, and the source changes both how many cells you get and how those cells behave. Bone marrow was the first source described, by Alexander Friedenstein's group in the late 1960s, and it remains the reference point. Fat tissue yields far more cells per gram, which is why most commercial collection now uses it.
Their main role, as far as current research can tell, is chemical signalling rather than rebuilding tissue themselves. They release growth factors, cytokines and small vesicles called exosomes, and those molecules tell nearby cells to dampen inflammation, build new blood vessels or stop dying. Only a small fraction of injected cells survive more than a few days in the body, which is exactly why the signalling explanation has largely replaced the older idea of cells physically becoming new cartilage.
That distinction is useful when reading a sales page. A product or clinic that says it replaces damaged tissue is describing something researchers have not demonstrated in humans, and the gap between a signalling effect measured in a lab and a rebuilt joint is the whole argument in this field.
Only for a few narrow conditions, and the list differs from country to country. In December 2024 the U.S. Food and Drug Administration approved Ryoncil, remestemcel-L, the first MSC-based therapy cleared in the United States, for steroid-refractory acute graft-versus-host disease in children. Japan approved Temcell for a similar indication in 2015, and the European Commission approved Alofisel in 2018 for complex perianal fistulas in Crohn's disease. Those are serious, specific, hospital-administered indications.
Everything else, including knees, backs, lungs, autism and anti-aging, remains investigational. A clinic advertising those uses is generally not working from an approval: it is selling a procedure that regulators have not cleared, which is permitted in some jurisdictions and not in others. That is not an accusation of bad faith; it is a description of where the paperwork stands.
A bone marrow transplant moves hematopoietic stem cells, the blood-forming kind, not mesenchymal cells. That procedure has decades of evidence behind it for leukaemia, lymphoma and certain inherited blood disorders, and it is standard hospital care with its own serious risks. When people say that stem cell medicine works, this is usually the field they are thinking of, and it has very little in common with an injection into a knee at a wellness clinic.
No. Placenta extract capsules, including the ones sold on this site, contain no living cells of any kind. Live cells do not survive processing into a dry capsule, and they would not survive stomach acid if they did. What an oral extract provides is a nutrient and peptide profile taken from the tissue, which is why it is sold as a wellness supplement.
This is a different product category from a clinical MSC procedure, not a budget version of one. The capsules are not a medical treatment, they are not indicated for any disease, and they do not replace anything a physician prescribes. Our 30-capsule bottle is 239.95 dollars and the 60-capsule bottle is 479.90, which is the price of a supplement, not of a procedure; if you are weighing a clinical procedure, that conversation belongs with a physician.
Ask for specifics in writing, and treat vagueness as the answer. A legitimate programme can tell you the cell source, the dose, who performs the injection and what the follow-up looks like; a sales operation tends to answer with testimonials and a payment plan. The questions below are the short version.
These capsules are a wellness supplement, not a medical treatment. They do not contain live stem cells and are not intended to diagnose, treat, cure or prevent any disease. Talk to your doctor before starting any supplement, especially if you have a diagnosed condition or take medication.
No. Mesenchymal stem cells come from adult tissue such as bone marrow and fat, or from donated birth tissue like cord and placenta. No embryos are involved, which is why they sit in a completely different ethical and regulatory category.
Clinics commonly advertise between 5,000 and 25,000 US dollars per session, and the quote often excludes imaging, follow-up and travel. Insurance generally does not cover investigational uses, so these are usually out-of-pocket costs. Ask what is included before paying a deposit.
No oral product has been shown in human studies to raise the number of mesenchymal stem cells in a person's body, and any product claiming that is ahead of the evidence. Placenta extract capsules are sold as a wellness supplement, not as a way to change your cell counts.
Because regulation differs by country and many of these procedures are paid for directly by patients rather than reimbursed by a health system. The research on joints is mostly early-phase, which is why regulators have not cleared it and why the price is quoted to you, not to an insurer.
Our bilingual team can orient you according to your case before any purchase.
Notice: this article is informational and is not medical advice. The products described are not a treatment or cure and do not replace diagnosis or care from a health professional.
